Intracellular and extracellular Hsp70 chaperone as a target for cancer therapy

International Journal of Hyperthermia

Volumn 29, Issue 5, 2013, Pages 399-408

  Guzhova, Irina V ^a   Shevtsov, Maxim A ^a   Abkin, Sergey V ^a   Pankratova, Katerina M ^a   Margulis, Boris A ^a  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

Author keywords

Anti tumour immunity; Apoptosis; Cancer; Heat shock proteins; Hsp70

Indexed keywords

ADENOSINE TRIPHOSPHATASE; B7 ANTIGEN; CASPASE 3; CASPASE 7; CASPASE 9; CHAPERONE; CHEMOKINE RECEPTOR CCR7; CYTOCHROME C; GRANZYME B; HEAT SHOCK PROTEIN 70; INTERLEUKIN 12; INTERLEUKIN 8; PHOSPHOLIPASE C; PROTEIN BAX;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTICLE; ARTIFICIAL MEMBRANE; CANCER SURVIVAL; CANCER THERAPY; CELL CYCLE ARREST; CELL SURVIVAL; CONFORMATIONAL TRANSITION; EXTRACELLULAR MATRIX; FOLLOW UP; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULARLY TARGETED THERAPY; NONHUMAN; PHOTODYNAMIC THERAPY; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION;

EID: 84881191318     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2013.807439     Document Type: Article

References (106)

1. Hartl FU, Hayer-Hartl M. Molecular chaperones in the cytosol: From nascent chain to folded protein. Science 2002;295:1852-8. (Pubitemid 34214115)
2. Young JC, Barral JM, Ulrich Hartl F. More than folding: Localized functions of cytosolic chaperones. Trends Biochem Sci 2003;28: 541-7. (Pubitemid 38366280)
3. Asea A. Initiation of the Immune Response by Extracellular Hsp72: Chaperokine Activity of Hsp72. Curr Immunol Rev 2006;2:209-15.
4. Li GC, Mivechi NF, Weitzel G. Heat shock proteins, thermotolerance, and their relevance to clinical hyperthermia. Int J Hyperthermia 1995;11:459-88.
5. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005;10:86-103. (Pubitemid 40942470)
6. Powers MV, Jones K, Barillari C, Westwood I, van Montfort RL, Workman P. Targeting HSP70: The second potentially druggable heat shock protein and molecular chaperone? Cell Cycle 2010;9: 1542-50.
7. Chuma M, Sakamoto M, Yamazaki K, Ohta T, Ohki M, Asaka M, et al. Expression profiling in multistage hepatocarcinogenesis: Identification of Hsp70 as a molecular marker of early hepatocellular carcinoma. Hepatology 2003;37:198-207. (Pubitemid 36042161)
8. Syrigos KN, Harrington KJ, Karayiannakis AJ, Sekara E, Chatziyianni E, Syrigou EI, et al. Clinical significance of heat shock protein-70 expression in bladder cancer. Urology 2003;61: 677-80. (Pubitemid 36294216)
9. Hwang TS, Han HS, Choi HK, Lee YJ, Kim YJ, Han MY, et al. Differential, stage-dependent expression of Hsp70, Hsp110 andBcl-2 incolorectal cancer. J Gastroenterol Hepatol 2003;18: 690-700. (Pubitemid 36791708)
10. Novoselov SS, Verbova MV, Vasil'eva EV, Vorob'eva NK, Margulis, BA, Guzhova IV. Expression of Hsp70 and Hdj1 chaperone proteins in human tumor cells. Vopr Onkol 2004;50: 174-8. (Pubitemid 39164014)
11. Nylandsted J, Rohde M, Brand K, Bastholm L, Elling F, Jäättelä M. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci USA 2000;97:7871-6. (Pubitemid 30460740)
12. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. Heat shock proteins in cancer: Chaperones of tumorigenesis. Trends Biochem Sci 2006;31:164-72. (Pubitemid 43361923)
13. Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol 2000;2:476-83.
14. Beere HM, Wolf BB, Mosser DD, Mahboubi A, Kuwana T, Tailor P, et al. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2000;2:469-75.
15. Stankiewicz AR, Lachapelle G, Foo CP, Radicioni SM, Mosser DD. Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation. J Biol Chem 2005;280:38729-39. (Pubitemid 43853776)
16. Ruchalski KL, Mao H, Li Z, Wang Z, Gillers S, Wang Y, et al. Distinct Hsp70 domains mediate apoptosis inducing factor release and nuclear accumulation. J Biol Chem 2006;281:7873-80. (Pubitemid 43847403)
17. Cande C, Cohen I, Daugas E, Ravagnan L, Larochette N, Zamzami N, et al. Apoptosis-inducing factor (AIF): A novel caspase-independent death effector released from mitochondria. Biochimie 2002;84:215-22.
18. Komarova EY, Afanasyeva EA, Bulatova MM, Cheetham ME, Margulis BA, Guzhova IV. Downstream caspases are novel targets for the anti-apoptotic activity of the molecular chaperone Hsp70. Cell Stress Chaperones 2004;9:265-75. (Pubitemid 39457430)
19. Jäättelä M. Overexpression of major heat shock protein hsp70 inhibits tumor necrosis factor-induced activation of phospholipase A2. J Immunol 1993;151:4286-94. (Pubitemid 23298762)
20. Mosser DD, Caron AW, Bourget L, Meriin AB, Sherman MY, Morimoto RI, et al. The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol 2000;20: 7146-59.
21. Nylandsted J, Gyrd-Hansen M, Danielewicz A, Fehrenbacher N, Lademann, U, Hoyer-Hansen M, et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 2004;200:425-35. (Pubitemid 39121900)
22. Kroemer G, Jäättelä M. Lysosomes and autophagy in cell death control. Nat Rev Cancer 2005;5:886-97. (Pubitemid 41746033)
23. Yaglom JA, Gabai VL, Sherman MY. High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways. Cancer Res 2007;67:2373-81. (Pubitemid 46424259)
24. Meng L, Hunt C, Yaglom JA, Gabai VL, Sherman MY. Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis. Oncogene 2011;30:2836-45.
25. Akerfelt M, Morimoto RI, Sistonen L. Heat shock factors: Integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol 2010;11:545-55.
26. Nagai N, Nakai A, Nagata K. Quercetin suppresses heat shock response by down regulation of HSF1. Biochem Biophys Res Commun 1995;208:1099-105.
27. Powers MV, Workman P. Inhibitors of the heat shock response: Biology and pharmacology. FEBS Lett 2007;581:3758-69. (Pubitemid 47081010)
28. Yokota S, Kitahara M, Nagata K. Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells. Cancer Res 2000;60:2942-8. (Pubitemid 30395819)
29. Westerheide SD, Kawahara TL, Orton K, Morimoto RI. Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J Biol Chem 2006;281: 9616-22. (Pubitemid 43864680)
30. Sahin E, Sahin M, Sanlioǧlu AD, Gümüslü S. KNK437, a benzylidene lactam compound, sensitises prostate cancer cells to the apoptotic effect of hyperthermia. Int J Hyperthermia 2011;27: 63-73.
31. Song X, Chen Z, Wu C, Zhao S. Abrogating HSP response augments cell death induced by As2O3 in glioma cell lines. Can J Neurol Sci 2010;37:504-11.
32. Mamelak D, Lingwood C. The ATPase domain of hsp70 possesses a unique binding specificity for 30-sulfogalactolipids. J Biol Chem 2001;276:449-56. (Pubitemid 32050338)
33. Rodina A, Vilenchik M, Moulick K, Aguirre J, Kim J, Chiang A, et al. Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer. Nat Chem Biol 2007;3: 498-507. (Pubitemid 47080368)
34. Braunstein MJ, Scott SS, Scott CM, Behrman S, Walter P, Wipf P, et al. Antimyeloma effects of the heat shock protein 70 molecular chaperone inhibitor MAL3-101. J Oncol 2011;2011: 232037.
35. Wisén S, Bertelsen EB, Thompson AD, Patury S, Ung P, Chang L, et al. Binding of a small molecule at a protein-protein interface regulates the chaperone activity of hsp70-hsp40. ACS Chem Biol 2010;5:611-22.
36. Leu JI, Pimkina J, Frank A, Murphy ME, George DL. A small molecule inhibitor of inducible heat shock protein 70. Mol Cell 2009;36:15-27.
37. Goloudina AR, Demidov ON, Garrido C. Inhibition of HSP70: A challenging anti-cancer strategy. Cancer Lett 2012;325:117-24.
38. Leu JI, Pimkina J, Pandey P, Murphy ME, George DL. HSP70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells. Mol Cancer Res 2011;9:936-47.
39. Schmitt E, Maingret L, Puig PE, Rerole AL, Ghiringhelli F, Hammann A, et al. Heat shock protein 70 neutralization exerts potent antitumor effects in animal models of colon cancer and melanoma. Cancer Res 2006;66:4191-7.
40. Tytell M, Greenberg SG, Lasek RJ. Heat shock-like protein is transferred from glia to axon. Brain Res 1986;363:161-4. (Pubitemid 16148032)
41. Hightower LE, Guidon Jr PT. Selective release from cultured mammalian cells of heat-shock (stress) proteins that resemble gliaaxon transfer proteins. J Cell Physiol 1989;138:257-66. (Pubitemid 19061205)
42. Guzhova I, Kislyakova K, Moskaliova O, Fridlanskaya I, Tytell M, Cheetham M, et al. In vitro studies show that Hsp70 can be released by glia and that exogenous Hsp70 can enhance neuronal stress tolerance. Brain Res 2001;914:66-73. (Pubitemid 32905432)
43. Yeh CH, Tseng R, Zhang Z, Cortes J, O'Brien S, Giles F, et al. Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia. Leuk Res 2009;33: 212-7.
44. Yeh CH, Tseng R, Hannah A, Estrov Z, Estey E, Kantarjian H, et al. Clinical correlation of circulating heat shock protein 70 in acute leukemia. Leuk Res 2010;34:605-9.
45. Dempsey NC, Leoni F, Ireland HE, Hoyle C, Williams JH. Differential heat shock protein localization in chronic lymphocytic leukemia. J Leukoc Biol 2010;87:467-76.
46. Nylandsted J. Extracellular heat shock protein 70: A potential prognostic marker for chronic myeloid leukemia. Leuk Res 2009; 33:205-6.
47. Kocsis J, Madaras B, Tóth EK, Füst G, Prohászka Z. Serum level of soluble70-kD heat shock protein is associated with high mortality in patients with colorectal cancer without distant metastasis. Cell Stress Chaperones 2010;15:143-51.
48. Elstner A, Stockhammer F, Nguyen-Dobinsky TN, Nguyen QL, Pilgermann I, Gill A, et al. Identification of diagnostic serum protein profiles of glioblastoma patients. J Neurooncol 2011;102: 71-80.
49. Dutta SK, Girotra M, Singla M, Dutta A, Otis Stephen F, Nair PP, et al. Serum HSP70: A novel biomarker for early detection of pancreatic cancer. Pancreas 2012;41:530-4.
50. Sherman M, Multhoff G. Heat shock proteins in cancer. Ann N Y Acad Sci 2007;1113:192-201. (Pubitemid 350015025)
51. Rérole AL, Jego G, Garrido C. Hsp70: Anti-apoptotic and tumorigenic protein. Methods Mol Biol 2011;787:205-30.
52. Murshid A, Gong J, Stevenson MA, Calderwood SK. Heat shock proteins and cancer vaccines: Developments in the past decade and chaperoning in the decade to come. Expert Rev Vaccines 2011;10: 1553-68.
53. Satoh M, Shimoda Y, Akatsu T, Ishikawa Y, Minami Y, Nakamura M. Elevated circulating levels of heat shock protein 70 are related to systemic inflammatory reaction through monocyte toll signal in patients with heart failure after acute myocardial infarction. Eur J Heart Fail 2006;8:810-5. (Pubitemid 44779418)
54. Molvarec A, Rigo Jr J, Lazar L, Balogh K, Mako V, Cervenak L, et al. Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia. Cell Stress Chaperones 2009;14:151-9.
55. Mitra S, Giesselman BR, Jesus-Andrino FJ, Foster TH. Tumor response to mTHPC-mediated photodynamic therapy exhibits strong correlation with extracellular release of Hsp70. Lasers Surg Med 2011;43:632-43.
56. Hurwitz MD, Kaur P, Nagaraja GM, Bausero MA, Manola J, Asea A. Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. Radiother Oncol 2010;95:350-8.
57. Schildkopf P, Frey B, Ott OJ, Rubner Y, Multhoff G, Sauer R, et al. Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages. Radiother Oncol 2011;101:109-15.
58. Jensen H, Andresen L, Hansen KA, Skov S. Cell-surface expression of Hsp70 on hematopoietic cancer cells after inhibition of HDAC activity. J Leukoc Biol 2009;86:923-32.
59. Lv LH, Wan YL, Lin Y, Zhang W, Yang M, Li GL, et al. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro. J Biol Chem 2012;287:15874-85.
60. Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin JP, et al. Membrane-associated Hsp72 from tumorderived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest 2010;120:457-71.
61. Dakappagari N, Neely L, Tangri S, Lundgren K, Hipolito L, Estrellado A, et al. An investigation into the potential use of serum Hsp70 as a novel tumour biomarker for Hsp90 inhibitors. Biomarkers 2010;15:31-8.
62. Mambula SS, Stevenson MA, Ogawa K, Calderwood SK. Mechanisms for Hsp70 secretion: Crossing membranes without a leader. Methods 2007;43:168-75. (Pubitemid 47499072)
63. Gastpar R, Gehrmann M, Bausero MA, Asea A, Gross C, Schroeder JA, et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res 2005;65:5238-47. (Pubitemid 40827334)
64. Radons J, Multhoff G. Immunostimulatory functions of membranebound and exported heat shock protein 70. Exerc Immunol Rev 2005;11:17-33.
65. Zhan R, Leng X, Liu X, Wang X, Gong J, Yan L, et al. Heat shock protein 70 is secreted from endothelial cells by a non-classical pathway involving exosomes. Biochem Biophys Res Commun 2009;387:229-33.
66. Juhász K, Thuenauer R, Spachinger A, Duda E, Horváth I, Vígh L, et al. Lysosomal rerouting of hsp70 trafficking as a potential immune activating tool for targeting melanoma. Curr Pharm Des 2013;19:430-40.
67. Evdonin AL, Martynova MG, Bystrova OA, Guzhova IV, Margulis BA, Medvedeva ND. The release of Hsp70 from A431 carcinoma cells is mediated by secretory-like granules. Eur J Cell Biol 2006;85:443-5.
68. Sashchenko LP, Dukhanina EA, Yashin DV, Shatalov YV, Romanova EA, Korobko EV, et al. Peptidoglycan recognition protein Tag7 forms a cytotoxic complex with heat shock protein 70 in solution and in lymphocytes. J Biol Chem 2004;279: 2117-24. (Pubitemid 38084485)
69. Arispe N, Doh M, Simakova O, Kurganov B, De Maio A. Hsc70 and Hsp70 interact with phosphatidylserine on the surface of PC12 cells resulting in a decrease of viability. FASEB J 2004;18: 1636-45. (Pubitemid 39463703)
70. Harada Y, Sato C, Kitajima K. Complex formation of 70-kDa heat shock protein with acidic glycolipids and phospholipids. Biochem Biophys Res Commun 2007;353:655-60. (Pubitemid 46048718)
71. Arispe N, Doh M, De Maio A. Lipid interaction differentiates the constitutive and stress-induced heat shock proteins Hsc70 and Hsp70. Cell Stress Chaperones 2002;7:330-8. (Pubitemid 36008745)
72. Triantafilou M, Triantafilou K. Heat-shock protein 70 and heat-shock protein 90 associate with Toll-like receptor 4 in response to bacterial lipopolysaccharide. Biochem Soc Trans 2004;32:636-9. (Pubitemid 39120403)
73. Bausero MA, Gastpar R, Multhoff G, Asea A. Alternative mechanism by which IFN-gamma enhances tumor recognition: Active release of heat shock protein 72. J Immunol 2005;175: 2900-12. (Pubitemid 41170507)
74. Ferrarini M, Heltai S, Zocchi MR, Rugarli C. Unusual expression and localization of heat-shock proteins in human tumor cells. Int J Cancer 1992;51:613-9.
75. Multhoff G, Botzler C, Wiesnet M, Mü ller E, Meier T, Wilmanns W, et al. A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer 1995;61:272-9.
76. Gastpar R, Gross C, Rossbacher L, Ellwart J, Riegger J, Multhoff G. The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells. J Immunol 2004;172:972-80. (Pubitemid 38113756)
77. Zhang H, Liu R, Huang W. A 14-mer peptide from HSP70 protein is the critical epitope which enhances NK activity against tumor cells in vivo. Immunol Invest 2007;36:233-46. (Pubitemid 46897669)
78. Stangl S, Themelis G, Friedrich L, Ntziachristos V, Sarantopoulos A, Molls M, et al. Detection of irradiation-induced, membrane heat shock protein 70 (Hsp70) in mouse tumors using Hsp70 Fab fragment. Radiother Oncol 2011;99:313-6.
79. Stangl S, Gehrmann M, Riegger J, Kuhs K, Riederer I, Sievert W, et al. Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. Proc Natl Acad Sci USA 2011;108: 733-8.
80. Srivastava PK. Immunotherapy for human cancer using heat shock protein-peptide complexes. Curr Oncol Rep 2005;7:104-8. (Pubitemid 40485465)
81. Noessner E, Gastpar R, Milani V, Brandl A, Hutzler PJ, Kuppner MC, et al. Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. J Immunol 2002;169: 5424-32. (Pubitemid 35291639)
82. Murshid A, Theriault J, Gong J, Calderwood SK. Investigating receptors for extracellular heat shock proteins. Methods Mol Biol 2011;787:289-302.
83. MacAry PA, Javid B, Floto RA, Smith KG, Oehlmann W, Singh M, et al. HSP70 peptide binding mutants separate antigen delivery from dendritic cell stimulation. Immunity 2004;20:95-106. (Pubitemid 38134297)
84. Wang Y, Whittall T, McGowan E, Younson J, Kelly C, Bergmeier LA, et al. Identification of stimulating and inhibitory epitopes within the heat shock protein 70 molecule that modulate cytokine production and maturation of dendritic cells. J Immunol 2005;174:3306-16. (Pubitemid 40354034)
85. Grossmann ME, Madden BJ, Gao F, Pang YP, Carpenter JE, McCormick D, et al. Proteomics shows Hsp70 does not bind peptide sequences indiscriminately in vivo. Exp Cell Res 2004;297: 108-17. (Pubitemid 38759566)
86. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002;277: 15028-34. (Pubitemid 34952579)
87. Asea A. Initiation of the immune response by extracellular Hsp72: Chaperokine activity of Hsp72. Curr Immunol Rev 2006;2:209-15.
88. Calderwood SK, Murshid A, Gong J. Heat shock proteins: Conditional mediators of inflammation in tumor immunity. Front Immunol. 2012;3:75.
89. Elsner L, Flügge PF, Lozano J, Muppala V, Eiz-Vesper B, Demiroglu SY, et al. The endogenous danger signals HSP70 and MICA cooperate in the activation of cytotoxic effector functions of NK cells. J Cell Mol Med 2010;14:992-1002.
90. Qiao Y, Liu B, Li Z. Activation of NK cells by extracellular heat shock protein 70 through induction of NKG2D ligands on dendritic cells. Cancer Immun 2008;8:12.
91. Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: Linking inflammation and cancer. J Immunol 2009;182:4499-506.
92. Geiger TL, Tauro S. Nature and nurture in Foxp3(+) regulatory T cell development, stability, and function. Hum Immunol 2012;73: 232-9.
93. Wachstein J, Tischer S, Figueiredo C, Limbourg A, Falk C, Immenschuh S, et al. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells. PLoS One 2012;7: e51747.
94. Borges TJ, Wieten L, van Herwijnen MJ, Broere F, van der Zee R, Bonorino C, et al. The anti-inflammatory mechanisms of Hsp70. Front Immunol 2012;3:95.
95. Evdonin AL, Guzhova IV, Margulis BA, Medvedeva ND. Extracellular heat shock protein 70 mediates heat stress-induced epidermal growth factor receptor transactivation in A431 carcinoma cells. FEBS Lett 2006;580:6674-8. (Pubitemid 44827028)
96. Wu FH, Yuan Y, Li D, Liao SJ, Yan B, Wei JJ, et al. Extracellular HSPA1A promotes the growth of hepatocarcinoma by augmenting tumor cell proliferation and apoptosis-resistance. Cancer Lett 2012; 317:157-64.
97. Calderwood SK, Mambula SS, Gray Jr PJ. Extracellular heat shock proteins in cell signaling and immunity. Ann N Y Acad Sci 2007; 1113:28-39.
98. Merchant S, Korbelik M. Heats shock protein 70 is acute phase reactant: Response elicited by tumor treatment with photodynamic therapy. Cell Stress Chaperones 2011;16:153-62.
99. He Y, Ge H, Li S. Haematoporphyrin based photodynamic therapy combined with hyperthermia provided effective therapeutic vaccine effect against colon cancer growth in mice. Int J Med Sci 2012;9:627-33.
100. Massa C, Guiducci C, Arioli I, Parenza M, Colombo MP, Melani C. Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70. Cancer Res 2004 Feb 15;64: 1502-8. (Pubitemid 38235623)
101. Geng H, Zhang G-M, Xiao H, Yuan Y, Li D, Zhang H, et al. HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma. Int J Cancer 2006;118:2657-64. (Pubitemid 43673341)
102. Chang C-L, Tsai Y-C, He L, Wu T-C, Hung C-F. Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70. Cancer Res 2007;67:10047-57. (Pubitemid 47621256)
103. Gong J, Zhu B, Murshid A, Adachi H, Song B, Lee A, et al. T Cell activation by heat shock protein 70 vaccine requires TLR signaling and scavenger receptor expressed by endothelial cells-1. J Immunol 2009;183:3092-8.
104. Ito A, Matsuoka F, Honda H, Kobayashi T. Atitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Immunol Immunother 2004;53:26-32. (Pubitemid 38161178)
105. Kumar S, Deepak P, Acharya A. Autologous Hsp70 immunization induces anti-tumor immunity and increases longevity and survival of tumor-bearing mice. Neoplasma 2009;56:259-68.
106. Abkin SV, Pankratova KM, Komarova EY, Guzhova IV, Margulis BA. Hsp70 chaperone-based gel composition as a novel immunotherapeutic anti-tumor tool. Cell Stress Chaperones 2012. doi 10.1007/s12192-012-0391-x.